TQB-3455
N/A
Report date: 2025/11/06 15:39:28
NME
Base Information
Drug NameTQB-3455
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJiangsu Chia Tai-Tianqing Pharmaceutical Co LtdLianyungang Runzhong Pharmaceutical Co LtdBeijing Centaurus Biopharma Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesNanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical GroupShouyao Holding (Beijing) Co LtdJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd +[4]
Inactive CompaniesN/A
Active Indications +[5]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A